mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.2 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.2 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.2 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.2 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |